Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q4 2025 | -29.33% |
| Q3 2025 | -78.11% |
| Q2 2025 | 10.89% |
| Q1 2025 | 0.34% |
| Q4 2024 | -71.34% |
| Q3 2024 | 25.75% |
| Q2 2024 | -47.00% |
| Q1 2024 | -18.16% |
| Q4 2023 | -36.98% |
| Q3 2023 | -7.47% |
| Q2 2023 | -25.97% |
| Q1 2023 | 26.84% |
| Q4 2022 | -22.62% |
| Q3 2022 | 2.00% |
| Q2 2022 | 2.25% |
| Q1 2022 | 2.19% |
| Q4 2021 | 45.69% |
| Q3 2021 | -33.38% |
| Q2 2021 | -3.61% |
| Q1 2021 | 15.91% |
| Q4 2020 | -39.29% |
| Q3 2020 | 9.33% |
| Q2 2020 | -70.80% |
| Q1 2020 | -8.38% |
| Q4 2019 | 28.63% |
| Q3 2019 | -132.94% |
| Q2 2019 | -78308.13% |
| Q1 2019 | 99.97% |
| Q4 2018 | 3.15% |
| Q3 2018 | 2.51% |
| Q2 2018 | 0.90% |
| Q1 2018 | -17.55% |
| Q4 2017 | -4.03% |
| Q3 2017 | 5.14% |
| Q2 2017 | -2.04% |
| Q1 2017 | -26.63% |
| Q4 2016 | 29.37% |
| Q3 2016 | 1.53% |
| Q2 2016 | 15.65% |
| Q1 2016 | 23.18% |